| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54 |
| filingDate |
2000-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2003-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2003502341-A |
| titleOfInvention |
Retro-inverso peptide derived from leukemia inhibitory factor |
| abstract |
(57) [Summary]nThe present invention relates to a retro-inverso peptide derived from leukemia inhibitory factor (LIF) having 18 to about 40 amino acids and comprising the sequence of SEQ ID NO: 1. The peptide has the same activity as native LIF and also has neurotrophic activity. Due to D-amino acid linkages within the peptides, they show less susceptibility to proteolysis in vivo. |
| priorityDate |
1999-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |